(Q43873500)

27 November 2017

title

Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management (English)

1 reference

positron emission tomography

27 November 2017

main subject

1 reference

D Rades

1

1 reference

27 November 2017

G Kühnel

2

1 reference

27 November 2017

I Wildfang

3

1 reference

27 November 2017

A R Börner

4

1 reference

27 November 2017

H J Schmoll

5

1 reference

27 November 2017

W Knapp

6

1 reference

27 November 2017

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

11

1 reference

27 November 2017

page(s)

1605-1609

1 reference

Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Applications of PET in lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

FDG PET in head and neck cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Detection of unknown occult primary tumors using positron emission tomography

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Relevance of positron emission tomography (PET) in oncology.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

The role of positron emission tomography (PET) in the management of lymphoma patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013107732572

7 January 2021

Identifiers

DOI

10.1023/A:1013107732572

1 reference

27 November 2017

1 reference